Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Hematopoietic stem cell dysfunction underlies the progressive lymphocytopenia in XLF/Cernunnos deficiency.

  • Read more about Hematopoietic stem cell dysfunction underlies the progressive lymphocytopenia in XLF/Cernunnos deficiency.

A(nother) RAF mutation in LCH.

  • Read more about A(nother) RAF mutation in LCH.

Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation.

  • Read more about Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation.

Mutations in GATA2 are rare in juvenile myelomonocytic leukemia.

  • Read more about Mutations in GATA2 are rare in juvenile myelomonocytic leukemia.

Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations.

  • Read more about Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations.

GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.

  • Read more about GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.

Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection.

  • Read more about Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection.

SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.

  • Read more about SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.

Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation.

  • Read more about Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation.

Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling.

  • Read more about Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling.

Pagination

  • Previous page ‹‹
  • Page 13
  • Next page ››
Subscribe to Blood

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List